Common Questions

Clarity Appraisals

Clarity Informatics create innovative IT solutions for the healthcare industry that improve patient safety and outcomes, save clinical time and are cost effective.

To register a new Clarity Appraisals account, you will need to go to the below link and complete the registration form: 

Click here to register if you are a Doctor

Click here to register if you are a Nurse

Go to www.appraisals.clarity.co.uk and choose the correct area you belong to. You will need to enter your registered email address and password, then click the ‘Login’ button.

If you have been taken to the subscription page this means that you do not currently have a subscription to use Clarity Appraisals. This will happen if you are logging in to the toolkit for the first time or if your subscription from last year has now expired.

If your password is not being accepted you should click the ‘Forgot your password?’ link, enter your registered email address, type the text shown in the ‘Captcha’ box and click the ‘Send’ button. This will send you an email to your registered email address which will contain a link. You need to click on the link, answer your Security Question and enter a new password. Finally click the ‘Renew’ button.

Yes, Clarity are ISO 27001 accredited and all data is held in a tier 3 data centre.

To update your registered email address for Clarity Appraisals, you will need to contact us on 0191 287 5800. This is for security purposes as we are unable to do this via email.

There is NO limit to the amount of documents that can be uploaded. Each user can upload and store an unlimited amount of documentation within the toolkit. There is a 10MB limit on the size of each file uploaded.

Yes, group discounts are available. The amount of discount is determined by the number of licences purchased. To find out the discount your organisation is entitled to please contact us.

Yes, Appraisals is continually developed with new releases being deployed almost every month. There is no downtime associated with any development release and therefore your ability to access Appraisals during this period will not be affected. 

The Clarity Support Team are accessible by phone or email to all users of Clarity Appraisals, and are available between the hours of 9am-5pm. The team are experts with Appraisals as well as regulatory requirements for appraisal and revalidation. They are dedicated to solving any issues you may have.

Clarity Appraisals for Doctors

Yes, the toolkit is compliant with MAGMAF standards.

No, appraiser access is free of charge and appraisers just need to contact the Clarity Support Team to have their access set up.

Yes, Clarity provides a patient feedback service for doctors who use Appraisals for Doctors for annual appraisal and revalidation. Packs can be ordered from the MSF section and are priced at £35 plus VAT. It is a fully administered service with access to the largest benchmarking data set of any toolkit/feedback software provider.

Clarity Appraisals for Nurses

Yes, the toolkit has been designed to be compliant with the NMC revalidation templates. Clarity Appraisals for Nurses can be used for documenting your revalidation evidence.

No, access for these roles is free of charge, appraisers/managers just need to contact the Clarity Support Team to have access setup. For your discussion partner/confirmer, you just need to input their email addresses/addresses to your revalidation dashboard.

Clinical Knowledge Summaries

CKS is underpinned by a rigorous editorial process that has been accredited by NICE. CKS topics are developed by a highly skilled and experienced multidisciplinary team and are based on the best available evidence. Existing knowledge from guidelines and systematic reviews is identified and gathered. Once reviewed the documents are appropriately amended and carefully checked prior to being issued.

CKS information specialists follow a structured search process to retrieve high quality, relevant information to provide a sound evidence base for our topics. The CKS search protocol follows a hierarchy of evidence from guidelines and systematic reviews, to primary research including RCTs, cohort and case-control studies.

The CKS authors are skilled to assess the evidence identified by the structured literature review so that the recommendations can be formulated from the best available evidence. The best available evidence is selected to formulate recommendations and provide accurate background information (for example, on incidence and prevalence).

  • Where available, CKS summarizes high quality guidance in which recommendations have been rigorously developed using appraised and synthesized studies (for example, NICE guidelines). Guidelines are assessed for quality by the clinical authors using the principles outlined by the AGREE Collaboration.
Each recommendation is based on an interpretation of the best available evidence. Where guidance assessed to be of adequate quality has been identified by the structured literature review (for example, a guideline from the National Institute for Health and Clinical Excellence), the recommendations from the source guidance are incorporated into CKS.
Each clinical question about management is answered by a clear recommendation (or set of recommendations), and it is clear to users:
  • Why the recommendation was made (that is, the move from the evidence to the recommendation), and
  • What is the quality of the evidence on which the recommendation is based, and
  • What is the strength of the recommendation — would most healthcare professionals and patients choose to follow the intervention (strong recommendation), or are patient values likely to vary, or does service availability vary with geographical location (weak recommendation)?

CKS selects and recommends drugs or devices, where appropriate, for the management of a condition and includes sufficient information to support the safe administration of, or writing of a prescription for, the selected drugs or devices.

Prescription details are not included for every possible product that might be appropriate to prescribe as (a) presenting a large number of possible products to prescribe can be overwhelming and as such does not support decision making and (b) these are listed in the British National Formulary.

CKS provides users with information and guidance that supports current best practice and national policy. Publication of new or updated guidance from the National Institute for Health and Care Excellence (NICE) and other key national policies, safety information, and changes to the availability of recommended drugs and devices will trigger an update to CKS topics.
Yes we are completely free of bias. We produce our advice and recommendations independently. To reduce the risk of bias in CKS recommendations, members of the CKS authoring team, expert advisers, external reviewers of CKS topics, and individuals providing feedback on published CKS topics are required to declare any competing interests.